financetom
Business
financetom
/
Business
/
Vitol group submits bid above $10 bln for Citgo's parent, sources say
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Vitol group submits bid above $10 bln for Citgo's parent, sources say
Jul 2, 2025 7:12 AM

HOUSTON, July 2 (Reuters) -

A group led by commodities trading house Vitol submitted a

bid exceeding $10 billion in the final hours of a

court-organized auction of shares in the parent of

Venezuela-owned refiner Citgo Petroleum, two sources with

knowledge of the offer told Reuters on Wednesday.

A Delaware court officer overseeing the auction is expected

to recommend a winner on Wednesday unless he requests more time

to evaluate bids submitted in the last minute.

Proceeds from the auction of PDV Holding, parent of the

seventh largest U.S. refiner, are meant to compensate at least a

handful of the 15 creditors fighting since 2017 to recover

nearly $19 billion in U.S. courts after Venezuela expropriated

assets and defaulted on debt.

The Vitol-led group's offer includes about $5 billion in

cash and the remaining amount in credit bids covering up to 14

claims, and it also includes a provision to pay holders of a

defaulted Venezuelan bond, one of the sources said.

Vitol did not immediately reply to a request for comment.

Vitol participated in a first bidding round for PDV Holding

last year and in a competition earlier this year to select a

starting bid, which was won by Red Tree Investments with a $3.7

billion offer. But new

bidders

have emerged in the last mile of the auction, following

court decisions in parallel legal cases that have encouraged new

and improved offers.

An

offer

approaching the same amount by a consortium led by

Chicago-based Black Lion Capital Advisors was also submitted in

recent days, while a consortium led by a subsidiary on miner

Gold Reserve ( GDRZF ) said it submitted two revised offers.

(Reporting by Marianna Parraga; Editing by Julia Symmes-Cobb and

Chizu Nomiyama )

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Japan's union group Rengo announces biggest wage hikes on record
Japan's union group Rengo announces biggest wage hikes on record
Mar 22, 2024
TOKYO (Reuters) -Japanese firms have agreed to raise pay by 5.25% this year, the biggest rise under comparable data since 2013, the country's largest union group Rengo confirmed on Friday. The results of the closely-watched wage negotiations are announced in several stages, in which the blue-chip firms are first to wrap up their talks in mid-March. The second announcement on...
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Mar 22, 2024
(Reuters) - Popular investor Cathie Wood's ARK Invest bought nearly 10,000 shares of Reddit ( RDDT ) in the social media platform's strong market debut on Thursday, an email from the asset manager showed. A total of 9,982 shares of the loss-making company was added to ARK Next Generation Internet ETF ( ARKW ) and ARK Fintech Innovation ETF (...
Once a beacon of stability, Vietnam to name third president in a year
Once a beacon of stability, Vietnam to name third president in a year
Mar 22, 2024
HANOI, March 22 (Reuters) - Communist-ruled Vietnam is seeking its third president in little more than a year after the resignation of Vo Van Thuong, who was only elected last year after the sudden dismissal of his predecessor. With accumulated foreign direct investment higher than its gross domestic product, Vietnam's stability is crucial to multinationals with large operations in the...
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Mar 22, 2024
05:04 AM EDT, 03/22/2024 (MT Newswires) -- Hutchmed ( HCM ) said late Thursday it has started the registration stage for a phase 2/3 clinical trial of investigational drug sovleplenib for adult patients with warm antibody autoimmune hemolytic anemia in China. The move follows positive data from the proof-of-concept phase 2 stage of the trial and a consultation with the...
Copyright 2023-2026 - www.financetom.com All Rights Reserved